News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter

Ventria Bioscience Launches Lacromin(TM) A Plant-Derived Growth Factor For Cell Culture Media

10/19/2005 5:11:57 PM

SACRAMENTO, Calif., July 19 /PRNewswire/ -- Ventria Bioscience has announced the introduction of a new plant-derived recombinant growth factor for cell culture media that improves productivity and safety. Lacromin(TM) is a strong growth factor and outperforms Transferrin, a common animal-derived growth factor. Lacromin(TM) was introduced today at the "Raw Materials and Disposable Process Systems for Mammalian Cell Products Conference" in Kansas City, Missouri.

(Logo: )

"We are excited about Lacromin(TM) to improve the productivity and safety of cell culture manufacturing," said Scott Deeter, President and CEO, Ventria Bioscience. "Given the FDA's preference for non-animal derived cell culture media ingredients, plant-derived proteins like Lacromin(TM) are a real breakthrough for this market."

"We are very encouraged by the positive results we have generated on Lacromin(TM)," said Ning Huang, Vice President of Research and Development, Ventria Bioscience. "At the conference today, I presented results showing Lacromin(TM) significantly increased the productivity of antibody production when compared with animal-derived transferrin."

Ventria Bioscience will market Lacromin(TM) to companies that seek a serum-free and animal component free cell culture media source for their biopharmaceutical production.

About Lacromin(TM)

Lacromin(TM) is recombinant human lactoferrin derived from plants. Lacromin(TM) holds many advantages over current cell culture media ingredients:

* Strong growth factor Lacromin(TM) has been shown to promote cell growth in many cell lines, including Chinese Hamster Ovary (CHO) cells and Mouse Hybridoma cells. * Outperforms Transferrin Lacromin(TM) promotes higher cell density and reduces cell doubling time when compared with Transferrin. * Replaces Animal Derived Transferrin Since Lacromin(TM) is derived from plants, it is free of any viral or prion contaminant risks. * Improves IgG Productivity In Hybridoma cells, Lacromin(TM) increased IgG productivity by 50% versus Transferrin and by 6% versus Fetal Bovine Serum (FBS).

Lacromin(TM) is offered for sale from Ventria Bioscience in 100 gram, 1 kilogram and 5 kilogram quantities. Pricing of Lacromin(TM) is available upon request.

About Ventria Bioscience

Ventria Bioscience is a biopharmaceutical company commercializing products that enhance human health. In addition to Lacromin(TM) for the cell culture market, Ventria has several products in development for human health applications.

For more information about Ventria Bioscience, see our website at

Statements in this announcement other than historical data and information constitute forward looking statements that involve risks and uncertainties that could cause actual results to differ materially from those stated or implied by such forward-looking statements. Potential risks and uncertainties may include, but are not limited to, recent changes in senior management, fluctuations in operating results, market conditions and changes in technology and increased competition.

Photo: Archive: http://photoarchive.ap.orgPRN Photo Desk, photodesk@prnewswire.comVentria Bioscience

CONTACT: Brandy Sargent, +1-916-921-6148, or

Read at

comments powered by Disqus